Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Details Textual)

v3.6.0.2
Basis of Presentation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Apr. 13, 2016
May 15, 2015
Jan. 25, 2016
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2016
Jun. 30, 2015
Basis of Presentation [Line Items]              
Accumulated deficit       $ (63,881)   $ (57,591)  
Net Cash Used in Operating Activities       (5,837) $ (2,814)    
Stock Issued During Period, Shares, New Issues 6,500,000            
Cash and Cash Equivalents, at Carrying Value, Total       $ 16,329 $ 6,732 $ 23,014 $ 9,494
Common Stock, Par or Stated Value Per Share       $ 0.001   $ 0.001  
Aspire Capital Fund Llc [Member] | Maximum [Member]              
Basis of Presentation [Line Items]              
Sale of Stock, Consideration Received on Transaction   $ 15,000          
iBio CMO [Member] | Eastern [Member]              
Basis of Presentation [Line Items]              
Stock Issued During Period, Shares, New Issues     3,500,000        
Stock Issued During Period, Shares, Acquisitions     10,000,000 10,000,000      
Common Stock, Par or Stated Value Per Share       $ 0.622      
Class Of Warrants Or Rights Exercised     1,784,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.53        
Proceeds From Capitalization Received     $ 15,000        
Stock Issued During Period, Value, Acquisitions     $ 7,200